Form 8-K - Current report:
SEC Accession No. 0000950170-25-112949
Filing Date
2025-09-04
Accepted
2025-09-04 06:01:45
Documents
64
Period of Report
2025-09-04
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cgem-20250904.htm   iXBRL 8-K 46543
2 EX-99.1 cgem-ex99_1.htm EX-99.1 77983
3 GRAPHIC cgem-ex99_1s1.jpg GRAPHIC 352595
4 GRAPHIC cgem-ex99_1s2.jpg GRAPHIC 824981
5 GRAPHIC cgem-ex99_1s3.jpg GRAPHIC 537226
6 GRAPHIC cgem-ex99_1s4.jpg GRAPHIC 426864
7 GRAPHIC cgem-ex99_1s5.jpg GRAPHIC 314413
8 GRAPHIC cgem-ex99_1s6.jpg GRAPHIC 560034
9 GRAPHIC cgem-ex99_1s7.jpg GRAPHIC 455798
10 GRAPHIC cgem-ex99_1s8.jpg GRAPHIC 471377
11 GRAPHIC cgem-ex99_1s9.jpg GRAPHIC 388978
12 GRAPHIC cgem-ex99_1s10.jpg GRAPHIC 298414
13 GRAPHIC cgem-ex99_1s11.jpg GRAPHIC 349435
14 GRAPHIC cgem-ex99_1s12.jpg GRAPHIC 327773
15 GRAPHIC cgem-ex99_1s13.jpg GRAPHIC 357057
16 GRAPHIC cgem-ex99_1s14.jpg GRAPHIC 377158
17 GRAPHIC cgem-ex99_1s15.jpg GRAPHIC 360303
18 GRAPHIC cgem-ex99_1s16.jpg GRAPHIC 520880
19 GRAPHIC cgem-ex99_1s17.jpg GRAPHIC 321495
20 GRAPHIC cgem-ex99_1s18.jpg GRAPHIC 317089
21 GRAPHIC cgem-ex99_1s19.jpg GRAPHIC 498318
22 GRAPHIC cgem-ex99_1s20.jpg GRAPHIC 321977
23 GRAPHIC cgem-ex99_1s21.jpg GRAPHIC 351230
24 GRAPHIC cgem-ex99_1s22.jpg GRAPHIC 491329
25 GRAPHIC cgem-ex99_1s23.jpg GRAPHIC 303723
26 GRAPHIC cgem-ex99_1s24.jpg GRAPHIC 358334
27 GRAPHIC cgem-ex99_1s25.jpg GRAPHIC 363604
28 GRAPHIC cgem-ex99_1s26.jpg GRAPHIC 483277
29 GRAPHIC cgem-ex99_1s27.jpg GRAPHIC 358510
30 GRAPHIC cgem-ex99_1s28.jpg GRAPHIC 325111
31 GRAPHIC cgem-ex99_1s29.jpg GRAPHIC 309104
32 GRAPHIC cgem-ex99_1s30.jpg GRAPHIC 470985
33 GRAPHIC cgem-ex99_1s31.jpg GRAPHIC 312539
34 GRAPHIC cgem-ex99_1s32.jpg GRAPHIC 417347
35 GRAPHIC cgem-ex99_1s33.jpg GRAPHIC 439997
36 GRAPHIC cgem-ex99_1s34.jpg GRAPHIC 460389
37 GRAPHIC cgem-ex99_1s35.jpg GRAPHIC 390311
38 GRAPHIC cgem-ex99_1s36.jpg GRAPHIC 334120
39 GRAPHIC cgem-ex99_1s37.jpg GRAPHIC 353262
40 GRAPHIC cgem-ex99_1s38.jpg GRAPHIC 376158
41 GRAPHIC cgem-ex99_1s39.jpg GRAPHIC 437156
42 GRAPHIC cgem-ex99_1s40.jpg GRAPHIC 368250
43 GRAPHIC cgem-ex99_1s41.jpg GRAPHIC 403471
44 GRAPHIC cgem-ex99_1s42.jpg GRAPHIC 308095
45 GRAPHIC cgem-ex99_1s43.jpg GRAPHIC 373520
46 GRAPHIC cgem-ex99_1s44.jpg GRAPHIC 297624
47 GRAPHIC cgem-ex99_1s45.jpg GRAPHIC 314069
48 GRAPHIC cgem-ex99_1s46.jpg GRAPHIC 353687
49 GRAPHIC cgem-ex99_1s47.jpg GRAPHIC 306739
50 GRAPHIC cgem-ex99_1s48.jpg GRAPHIC 329510
51 GRAPHIC cgem-ex99_1s49.jpg GRAPHIC 257724
52 GRAPHIC cgem-ex99_1s50.jpg GRAPHIC 312765
53 GRAPHIC cgem-ex99_1s51.jpg GRAPHIC 301240
54 GRAPHIC cgem-ex99_1s52.jpg GRAPHIC 382759
55 GRAPHIC cgem-ex99_1s53.jpg GRAPHIC 357446
  Complete submission text file 0000950170-25-112949.txt   28332229

Data Files

Seq Description Document Type Size
56 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cgem-20250904.xsd EX-101.SCH 24922
66 EXTRACTED XBRL INSTANCE DOCUMENT cgem-20250904_htm.xml XML 4711
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Filer) CIK: 0001789972 (see all company filings)

EIN.: 813879991 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39856 | Film No.: 251291815
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)